FDA Grants Theranica De Novo to Market First Smartphone-controlled Acute Migraine-relief Wearable Device
Theranica, a bio-medical technology company developing advanced electroceuticals for migraine and other pain disorders, announced today that the U.S. Food and Drug Administration (FDA) granted a De Novo request for its smartphone-controlled electroceutical, Nerivio Migra®, [...]